Suk Wai Lam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suk Wai Lam has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Judith V. M. G. Bovée
Department of Pathology, Leiden University Medical Center
2 shared publications - Anne-Marie Cleton-Jansen
Department of Pathology Leiden University Medical Center Leiden The Netherlands
1 shared publication - Arjen H. G. Cleven
Department of Pathology and Medical Biology University Medical Center Groningen, University of Groningen Groningen The Netherlands
1 shared publication - Brendy Ewm van Den Akker
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
1 shared publication - Cemile Dilara Savci-Heijink
Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
1 shared publication - Daniel Baumhoer
University Hospital of Basel
1 shared publication
Latest Publications
- 27 April 2025
- Published by Springer Nature
- p. 73-80
Histological Challenges in the Intra-operative Stage
- 27 April 2025
- Published by Springer Nature
- p. 73-80
Histological Challenges in the Intra-operative Stage
- Open Access
- 3 June 2021
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 45 (12) , 1669-1681
Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors
A simple bone cyst (SBC) is a cystic bone lesion predominantly affecting young males. The cyst is lined by a fibrous membrane and filled with serosanguinous fluid. EWSR1/FUS-NFATC2 rearrangements were recently identified in SBC. We here report exactly the same rearrangement in 3 lesions diagnosed as vascular malformations of 2 elderly patients. In total, through Archer FusionPlex, fluorescence in situ hybridization and/or reverse transcriptase-polymerase chain reaction the EWSR1-NFATC2 rearrangement was identified in 6 of 9 SBC, 3 of 12 benign vascular tumors, and none of 5 aneurysmal bone cyst lacking USP6 fusion. Using fluorescence in situ hybridization, it was apparent that amplification of the fusion, as seen in EWSR1-NFATC2 round cell sarcomas, was absent, and that in the vascular tumors the fusion was present both in the lining cells as well as in the surrounding spindle cells. Of note, not all of the spaces in the vascular malformations were lined by endothelial cells. Aggrecan was positive in all cases but was not specific. NKX2-2 and NKX3-1 staining were negative in all cases. Thus, even though the overlap between the 2 entities is limited to the presence of few thick-walled cysts lacking endothelial lining in the benign vascular malformations, the spectrum of benign tumors containing NFATC2 fusions should be expanded and contains not only SBC in the young, but also vascular malformation/hemangioma in elderly patients.
- 3 June 2021
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 45 (12) , 1669-1681
Open AccessExpanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors
A simple bone cyst (SBC) is a cystic bone lesion predominantly affecting young males. The cyst is lined by a fibrous membrane and filled with serosanguinous fluid. EWSR1/FUS-NFATC2 rearrangements were recently identified in SBC. We here report exactly the same rearrangement in 3 lesions diagnosed as vascular malformations of 2 elderly patients. In total, through Archer FusionPlex, fluorescence in situ hybridization and/or reverse transcriptase-polymerase chain reaction the EWSR1-NFATC2 rearrangement was identified in 6 of 9 SBC, 3 of 12 benign vascular tumors, and none of 5 aneurysmal bone cyst lacking USP6 fusion. Using fluorescence in situ hybridization, it was apparent that amplification of the fusion, as seen in EWSR1-NFATC2 round cell sarcomas, was absent, and that in the vascular tumors the fusion was present both in the lining cells as well as in the surrounding spindle cells. Of note, not all of the spaces in the vascular malformations were lined by endothelial cells. Aggrecan was positive in all cases but was not specific. NKX2-2 and NKX3-1 staining were negative in all cases. Thus, even though the overlap between the 2 entities is limited to the presence of few thick-walled cysts lacking endothelial lining in the benign vascular malformations, the spectrum of benign tumors containing NFATC2 fusions should be expanded and contains not only SBC in the young, but also vascular malformation/hemangioma in elderly patients.